Ekaterina Smirnyagina - Adocia Independent Director

ADOC Stock  EUR 8.43  0.33  3.77%   

Director

Ms. Ekaterina Smirnyagina was Independent Director of Adocia SA since June 18, 2013. She is Member of the Remuneration Committee. After completing her Ph.D. in Microbiology Immunology at the Stanford School of Medicine, she began her career in the Consulting and Development Business of Biotechnology. She then worked at Alta Partners, an investment fund company specializing in health care in San Francisco from 2002 to 2012. Since then, she was a director of the Capricorn Venture Partners investment fund in Belgium. since 2013.
Age 52
Tenure 11 years
Phone(33) 04 72 36 39 67
Webwww.adocia.com

Adocia Management Efficiency

The company has return on total asset (ROA) of (0.245) % which means that it has lost $0.245 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.6138) %, meaning that it generated substantial loss on money invested by shareholders. Adocia's management efficiency ratios could be used to measure how well Adocia manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 18.29 M in total debt with debt to equity ratio (D/E) of 4.45, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Adocia has a current ratio of 3.33, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Adocia until it has trouble settling it off, either with new capital or with free cash flow. So, Adocia's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Adocia sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Adocia to invest in growth at high rates of return. When we think about Adocia's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

DIRECTOR Age

Abdulqader MaamarItissalat Al Maghrib
N/A
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Adocia SA was founded in 2005 and is headquartered in Lyon, France. ADOCIA operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 116 people. Adocia (ADOC) is traded on Euronext Paris in France and employs 110 people.

Management Performance

Adocia Leadership Team

Elected by the shareholders, the Adocia's board of directors comprises two types of representatives: Adocia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adocia. The board's role is to monitor Adocia's management team and ensure that shareholders' interests are well served. Adocia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adocia's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jose Correia, Head of the Preclinical and Clinical Department, HSQE Manager and Project Manager
Valerie Danaguezian, Chief Financial Officer, Administrative Director
Ekaterina Smirnyagina, Independent Director
Laurent Arthaud, Director Representative of Bpifrance Investissement
Remi Soula, Co-Founder, Director of Bus. Devel. and Intellectual Property and Scientific Advisor
Valrie Danaguezian, CFO Director
Grard Soula, Chairman, CoFounder
Geraldine Soula, Director of Development and Human Resources
Olivier MBA, Deputy CoFounder
Emmanuel Dauty, Head of Physical Chemistry
Olivier Martinez, Member of the Board
Gerard Soula, Chairman of the Board, Chief Executive Officer
Bertrand Alluis, Head of Analysis Department and Project Manager
Joachim Garric, Head of Analysis Department
Walter Roger, Head of Industrial Property Department
Dominique Takizawa, Independent Member of the Board
Martin Gaudier, Head of Biology Department
Olivier Soula, Deputy Chief Executive Officer, Vice President - Research & Development, Director
David Duracher, Head of Pharmaceutical Development and Physical Chemistry Departments
Frederic Leroy, Head of Chemistry Department
Gregory Meiffren, Head of Biology Department
YouPing Chan, Scientific Director
Stanislav Glezer, Medical Doctor
Grgory Meiffren, Head Mang
Sarah Gould, Director of the Preclinical Department
Richard Charvet, Head of Chemistry Department

Adocia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adocia a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adocia in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adocia's short interest history, or implied volatility extrapolated from Adocia options trading.

Pair Trading with Adocia

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adocia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adocia will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adocia Stock

  0.61ALBPK Broadpeak SAPairCorr
  0.61ALCAR CarmatPairCorr
  0.76ALMDT MediantechnPairCorr

Moving against Adocia Stock

  0.6ALMDP Medesis Pharma SAPairCorr
The ability to find closely correlated positions to Adocia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adocia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adocia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adocia to buy it.
The correlation of Adocia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adocia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adocia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adocia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adocia. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Adocia Stock analysis

When running Adocia's price analysis, check to measure Adocia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adocia is operating at the current time. Most of Adocia's value examination focuses on studying past and present price action to predict the probability of Adocia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adocia's price. Additionally, you may evaluate how the addition of Adocia to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Please note, there is a significant difference between Adocia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adocia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adocia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.